High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial (Q45048847)
scientific article published on 7 September 2004
Language:
(P31) (Q13442814)
(P50) (Q62567829)
(Q80167861)
(Q92241539)
(P304) 1406-1412
(P407) (Q1860)
(P433) 11
(P478) 110
(P577) Tuesday, September 7, 2004
(P921) (Q181600)
(Q266018)
(P1433) (Q578091)
(P1476) "High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial" (language: en)
(P2093) Elizabeth R Miller
William J Sasiela
Anders G Olsson
Gregory G Schwartz
Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
other details
description scientific article published on 7 September 2004

External Links